Earnings Releases, Strategic Acquisitions, Upcoming Events, and Alliances - Analyst Notes on PAT, DCC, Euromoney, Supergroup and Whitbread
LONDON, June 27, 2014 /PRNewswire/ --
- Editor Note: For more information about this release, please scroll to bottom.
Today, Earnings Review released its analysts' notes regarding Personal Assets Trust Plc (LON: PNL), DCC Plc (LON: DCC), Euromoney Institutional Investor Plc (LON: ERM), Supergroup Plc (LON: SGP) and Whitbread Plc (LON: WTB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://earnings-review.com/4209-100free.
--
Personal Assets Trust Plc Analyst Notes
On June 5, 2014, Personal Assets Trust Plc (PAT) released results for FY 2014 (period ended April 30, 2014). For the 12-month period ended April 30, 2014, PAT's Net Asset Value (NAV) per share fell by 5.1%, as against a 6.8% rise in the benchmark - the FTSE All-Share Index. PAT informed that the first interim dividend of £1.40 per ordinary share will be paid to shareholders on July 17, 2014 and three further interim dividends of £1.40 per ordinary share are expected to be paid to shareholders in the year ending April 30, 2015, totaling £5.60 for the year. The Company notified that it has continued to experience demand for its shares and in FY 2014, it issued 61,683 ordinary shares, purchased 37,992 Ordinary shares to be held in Treasury then re-issued 7,855 of these shares, raising £11.7 million of net new capital. The full analyst notes on PAT are available to download free of charge at:
http://earnings-review.com/4209-PNL-27Jun2014.pdf
--
DCC Plc Analyst Notes
On June 3, 2014, DCC Plc (DCC) reported that its healthcare division - DCC Healthcare's subsidiary DCC Vital has acquired Williams Medical Holdings, which supplies medical and pharmaceutical products and related services to general practitioners in Britain. DCC informed that the consideration was paid in cash at completion, based on an enterprise value of £45 million. As per DCC, Williams' acquisition will help DCC Vital expand and enhance its market coverage to primary care, community care and domiciliary care in the British and Irish healthcare markets. Tommy Breen, CEO, DCC, said, "The acquisition of Williams Medical represents an excellent strategic fit and another material step forward for DCC Healthcare following the acquisitions of Kent Pharma, Leonhard Lang UK and UPL over the last 15 months." The full analyst notes on DCC are available to download free of charge at:
http://earnings-review.com/4209-DCC-27Jun2014.pdf
--
Euromoney Institutional Investor Plc Analyst Notes
As per the financial calendar of Euromoney Institutional Investor Plc (Euromoney), the Company will release its Interim Management Statement on July 24, 2014. On May 15, 2014, Euromoney announced Interim Results for the six months to March 31, 2014. The Company reported revenue of £195.8 million for the period, up 4.5% YoY and adjusted diluted EPS of 32.0 pence, up 0.3% YoY. The Group intends to continue its strategy of investing in new products and digital publishing, mainly using the Delphi content platform, so as to aid organic growth, and to use its solid balance sheet and cash flows to finance future acquisitions. The full analyst notes on Euromoney are available to download free of charge at:
http://earnings-review.com/4209-ERM-27Jun2014.pdf
--
Supergroup Plc Analyst Notes
According to the Financial Calendar of Supergroup Plc (Supergroup), it will announce its full year results (period ended April 26, 2014) on July 10, 2014. Supergroup released its Q4 Interim Management Statement, for the period January 27, 2014 to April 26, 2014 on May 8 2014. As per the Interim Statement, total Group sales for Q4 2014 increased 12.4% YoY to £97.8 million. Total retail sales were up 13.3% YoY to £54.6 million and wholesale sales inched higher by 11.2% YoY to £43.2 million. SuperGroup is the owner of the Superdry brand and operates in the branded fashion clothing sector. The Group's strategy is to further internationalise the business, with the focus of its future rollout of owned stores on mainland Europe. The full analyst notes on Supergroup are available to download free of charge at:
http://earnings-review.com/4209-SGP-27Jun2014.pdf
--
Whitbread Plc Analyst Notes
On June 20, 2014, Whitbread Plc (Whitbread) owned Costa Coffee announced that it will partner with Debenhams to trial six new concessions across the department store's UK estate. Costa will launch in six Debenhams' stores: Guildford and Slough in June and Derby, Exeter, Haverfordwest and Woking in July. The first coffee shop at Guildford store opened on June 25, 2014. James Hamilton, UK Head of Acquisitions at Costa, quoted, "It is important for us to partner with other leading British retailers in order to deliver the best experience for coffee lovers. We see this as a mutually beneficial partnership; bringing together the nation's favourite coffee shop brand with one of the UK's leading department stores, allowing both brands to strengthen customer experience and further drive sales." The partnership provides a great strategic fit for the two UK brands, with both retailers possessing similar customer demographics, brand recognition and product quality. The full analyst notes on Whitbread are available to download free of charge at:
http://earnings-review.com/4209-WTB-27Jun2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] earnings-review.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] earnings-review.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] earnings-review.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Earnings Review in this article or report according to the procedures outlined by Earnings Review. Earnings Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Earnings Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Earnings Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Earnings-Review.com
Share this article